XOMA Corporation
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $40.7M
- Price
- $24.97
- % Change (Daily % change from the live per-ticker quote feed.)
- +0.04%
- Volume
- 2.2K
Quote data as of 6:15 AM ET
About
Based in Emeryville, California, and founded in 1981, XOMA Corporation functions as a specialized biotechnology royalty aggregator, with operations spanning Europe, the United States, and the Asia Pacific. The company's core mission is to contribute to advancing human health by empowering other biotechnology firms. XOMA achieves this by purchasing the future economic interests, often in the form of royalties, associated with therapeutic candidates still in their pre-commercial development stages, which have already been licensed to pharmaceutical or biotechnology partners. Their strategic focus is primarily on early to mid-stage clinical assets, specifically those in Phase 1 and 2, that demonstrate significant potential for commercial sales once fully developed by their licensees. Currently, XOMA manages a substantial portfolio comprising approximately 70 such assets.
Quick stats
Shares outstanding17.7M
Computed float13.0M
Float sourceUnknown
Cash runway (months)Unknown
Dilution risk—
Has warrants—
Has convertibles—
Active shelf (Shelf registration (e.g. Form S-3) currently in effect — the company is pre-cleared to issue and sell new shares quickly. A standing dilution risk.)—
Active ATM (At-the-market offering — a program to sell newly issued shares directly into the open market at prevailing prices, diluting existing holders over time.)—
Key info
SectorHealthcare
IndustryBiotechnology
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0000791908
Websitehttps://www.xoma.com